10:20 AM EDT, 05/07/2024 (MT Newswires) -- Neumora Therapeutics ( NMRA ) shares were down 2.5% in recent Tuesday trading after the company reported a Q1 loss of $0.34 per diluted share, narrower than a loss of $1.22 a year earlier.

Four analysts polled by Capital IQ expected a loss of $0.35.

As expected, the company did not report revenue for the quarter ended March 31.

Neumora said it had $423 million in cash, cash equivalents and marketable securities at the end of the quarter, which it said would enable it to fund its operating plan into 2026.

Price: 9.14, Change: -0.21, Percent Change: -2.27